Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (291-300 of 306) with videos related to

Pageof 31
Sort By:
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Daniele Di Paolo, Domenico Di Carlo, et al.
Viruses|July 11, 2018
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological TargetsLuna Colagrossi, Romina Salpini, Rossana Scutari, et al.
Journal of Medical Virology|May 6, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target TrialsValentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
Emerging Microbes & Infections|April 22, 2020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels <i>in vivo</i>, hinder HBsAg secretion <i>in vitro</i> and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infectionRomina Salpini, Arianna Battisti, Lorenzo Piermatteo, et al.
Eclinicalmedicine|March 20, 2023
Sarilumab plus standard of care <i>vs</i> standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Oncotarget|February 3, 2017
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitroRomina Salpini, Matteo Surdo, Nadia Warner, et al.
Brain Research Bulletin|February 1, 2022
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patientsClaudio Babiloni, Claudio Del Percio, Roberta Lizio, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Pageof 31

Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Daniele Di Paolo, Domenico Di Carlo, et al.
Viruses|July 11, 2018
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological TargetsLuna Colagrossi, Romina Salpini, Rossana Scutari, et al.
Journal of Medical Virology|May 6, 2025
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target TrialsValentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.
Emerging Microbes & Infections|April 22, 2020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels <i>in vivo</i>, hinder HBsAg secretion <i>in vitro</i> and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infectionRomina Salpini, Arianna Battisti, Lorenzo Piermatteo, et al.
Eclinicalmedicine|March 20, 2023
Sarilumab plus standard of care <i>vs</i> standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Oncotarget|February 3, 2017
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitroRomina Salpini, Matteo Surdo, Nadia Warner, et al.
Brain Research Bulletin|February 1, 2022
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patientsClaudio Babiloni, Claudio Del Percio, Roberta Lizio, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Pageof 31